As of 2025-05-03, the Fair Value of Iovance Biotherapeutics Inc (IOVA) is -5.68 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.50 USD, the upside of Iovance Biotherapeutics Inc is -262.16%.
With the market price of 3.50 USD and our fair value calculation, Iovance Biotherapeutics Inc (IOVA) is not a good investment. Investing in IOVA stocks now will result in a potential loss of 262.16%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -259.58 | -342.25 | -395.89 | -444.04 | -372.18 | -362.79 |
| YoY growth | -31.39% | -31.85% | -15.67% | -12.16% | 16.18% | -14.98% |
| Market Cap (mil) | 1,147.58 |
| P/E | |
| Forward P/E |
| EPS | -1.14 |
| Avg earnings growth rate | -14.98% |
| TTM earnings | -372.18 |